Connect with us

Are These 3 Apparel Stocks Falling Out of Style? Analysts Weigh In

Are These 3 Apparel Stocks Falling Out of Style? Analysts Weigh In

Published

on

Even before COVID-19, retail was in a tough spot. Turning up the heat, the virus and the ensuing store closures have had a devastating impact on the space. High unemployment rates and a shift in consumer shopping behavior have done little to help the situation. But just how destructive has the crisis been? 

According to a July report from S&P Global Market Intelligence, so far, 2020 has seen 40 retailers file for bankruptcy. This figure has already exceeded the number of retail bankruptcies in both 2019 and 2018. Based on tracking data from S&P Global, this year’s number could top the 48 filings in 2010, which was driven by the lethal impacts of the Great Recession.  

With a second wave of COVID-19 infections only intensifying pressures, more filings could be on the way. Bearing this in mind, we used TipRanks’ database to see if the pros on Wall Street think three apparel stocks in particular have what it takes to weather the COVID storm. 

Macy’s Inc. (M) 

Over the last 161 years, Macy’s has become one of the largest retail chains in the U.S. While the company has taken steps to drive a recovery, will these efforts be enough to keep it afloat? 

Writing for Deutsche Bank, four-star analyst Paul Trussell tells clients that traffic trends have been improving and applauds “management on taking aggressive cost-saving actions and a prudent approach to 2H outlook/ inventory receipts.” However, this by no means implies the outlook is rosy. 

“Nonetheless, our view on the stock remains relatively neutral, and we believe investor sentiment is also mixed as numerous headwinds remain, including: 1) increases in COVID-19 cases across the U.S. (potentially leading to a slowdown in traffic trends as already experienced in Texas); 2) an aggressive promotional backdrop as retailers work to move through Spring receipts; and 3) higher shipping costs due to increased penetration of digital sales,” Trussell explained. 

Looking at sales expectations, management is calling for a 35% decline in brick & mortar sales trends in the second half of 2020. Digital sales are only expected to see a high-teens gain even though trends have been strong recently. As for margins, Trussell points out “M now anticipates its merchandise margin to be better than its previous outlook leading to an improvement in the GPM rate in Q2 vs. Q1 with further improvement in the back half.” 

Reflecting another positive, M unveiled a new restructuring plan slated to yield expense savings of $365 million for 2020 and $630 million on an annualized basis. “These savings are additive to the anticipated $1.5 billion in annual expense savings announced back in February, which M expects to fully realize by year-end 2022,” Trussell added. 

To this end, Trussell thinks Q2 EPS could be better than he previously expected, but he still estimates the figure will land at a loss of $2.09. “In addition, our sales forecast includes brick & mortar comp down 67%... Looking at margins, we are forecasting GPM down 1,980 basis points and core SG&A dollar growth down 23% (leading to SG&A deleverage of 885 basis points),” he commented.  

Based on all of the above, Trussell stays on the sidelines, rating M a Hold. Along with the call, he increased the price target from $5 to $6. This figure implies shares could drop 7% in the year ahead. (To watch Trussell’s track record, click here

Turning now to the rest of the Street, other analysts take a more bearish approach. 3 Holds and 7 Sells add up to a Moderate Sell consensus rating. The $5.17 average price target brings the downside potential to 20%. (See Macy's price targets and analyst ratings on TipRanks

Kohl’s Corporation (KSS) 

Moving on to another major department store chain, 2020 has been brutal to Kohl’s, with shares falling 59% year-to-date. Even though it has been gaining traction with respect to its digital presence, there are still plenty of challenges ahead, according to some members of the Street. 

Wedbush’s Jen Redding points out that a 43.5% decline in net sales drove the weak Q1 performance, with KSS missing the estimates by a long shot. Alarmingly, gross margin plummeted by 2,000 basis points, versus the Street’s call for a decline of 330 basis points.  

What was behind the gross margin deterioration? Redding argues it was management’s inventory actions that included the establishment of a reserve for excess seasonal inventory, incremental promotions and clearance.  

Expounding on this, the analyst stated, “The company pulled back in March and April orders when COVID-19 first impacted the economy, reducing inventory receipts by over 30% in Q1 and expects to lower Q2 receipts by over 60%. The higher cost of shipping driven by digital sales and unfavorable product mix contributed to the decline in the margin as well.” 

The news does, however, get a bit better. During the quarter, digital sales jumped 24%, and the gain for April was 60%. As for digital penetration, it increased from 21% last year to 45% in the quarter.  

Redding explained, “During the quarter, more than 40% of digital orders were fulfilled by ship-from-store and customer pickup, and the number is much higher in April when the company launched store drive-up service, which has received great response from customers, making up 15% of digital demand fulfillment in over 900 stores that offers the new service, exceeding what BOPIS had pre-COVID. By category, Home was the strongest, increased by more than 50% in digital sales for the quarter, followed by active, toys and beauty, while similar to our Promo Trackers apparel and footwear lagged in the quarter.” 

Digital sales are still ramping up and many of its stores have reopened, but Redding believes lower sales and the incremental cost of shipping from higher digital sales could push gross margin lower. “The company expects SG&A to decline for the year, but the savings could be limited as stores implement new safety measures post-COVID,” she added.  

Summing it all up, Redding noted, “We could become more constructive on shares if inventories are managed tightly, promotional cadence reins in, traffic-driving initiatives begin to track within investor expectations for conversion, and if KSS's long term goals start to materialize ahead of pace in a post-COVID environment.” 

To this end, Redding kept her Neutral rating as is. Additionally, she gave the price target a trim, cutting it from $20 to $16. A twelve-month drop of 23% could be in store, should the analyst’s thesis play out in the next year. (To watch Redding’s track record, click here)         

Looking at the consensus breakdown, 3 Buys, 5 Holds and 2 Sells have been assigned in the last three months. So, KSS gets a Hold consensus rating. At $21.30, the average price target indicates 2% upside potential. (See Kohl's price targets and analyst ratings on TipRanks

Urban Outfitters (URBN) 

Fashion retailer Urban Outfitters also hasn’t been able to escape COVID-19's grasp, with its most recent quarterly performance making this especially clear. Now, investors are wondering if the situation could get even worse. 

Covering the stock for Deutsche Bank, analyst Tiffany Kanaga was most surprised by the company’s Q1 gross profit margin (GPM), which tumbled from 31.1% last year to 2% in the quarter. That said, management attributed the result to a series of one-time headwinds including a $43.3 million inventory obsolescence reserve increase, a $14.5 million provisional store impairment charge and product liability charges related to specific key suppliers. In addition, certain agreements with landlords could lead to a significant benefit for occupancy in Q2. 

However, that doesn’t mean GPM will bounce back anytime soon. “However, as the top-line recovery could take some time to gain traction (we expect Q2 comp at -30%, below Q1's -28%) especially as online was up only LDD in Q1 and store sales and traffic have been ‘tepid’ to date, we expect margin pressure to remain in focus for investors. The company had struggled to drive EBIT growth pre-virus (four straight quarters of 20%-plus declines in 2019) with a myriad of outsized GPM headwinds historically (down 614 basis points annually since 2013 vs. AEO up 77 basis points),” Kanaga explained. 

Throwing more bad news into the mix, Kanaga thinks sentiment surrounding URBN will most likely be poor. “We expect sentiment to lean negative post-print, as some modest signs of top-line acceleration likely fell below investor expectations, and are more than offset by nearly negative GPM with an underlying rate (i.e. excluding Q1's extraordinary impacts as outlined above) still implying significant ongoing margin pressure ahead,” she commented. 

As a result, Kanaga can’t recommend that investors snap up shares. The analyst noted, “Looking forward, we remain sidelined with 2021 EBIT modeled at only 40% of 2019's level, reflecting ongoing challenges through sales deleverage, e-commerce mix impact, wholesale headwinds, and promotional pressure.” 

To accompany her Hold rating, Kanaga reduced the price target from $16 to $15. The implication for investors? Possible downside of 3%. (To watch Kanaga’s track record, click here)        

Most other analysts agree with Kanaga’s assessment. With 4 Buys, 8 Holds and 1 Sell handed out in the last three months, the word on the Street is that URBN is a Hold. However, the $18.82 average price target puts the upside potential at 22%. (See Urban Outfitters price targets and analyst ratings on TipRanks

The post Are These 3 Apparel Stocks Falling Out of Style? Analysts Weigh In appeared first on TipRanks Financial Blog.

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending